Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-097006
Filing Date
2025-07-18
Accepted
2025-07-18 17:20:39
Documents
1
Period of Report
2025-07-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4658
  Complete submission text file 0000950170-25-097006.txt   6062
Mailing Address C/O GENERATION BIO CO. 301 BINNEY STREET, SUITE 401 CAMBRIDGE MA 02142
Business Address
Kerr Douglas (Reporting) CIK: 0001814189 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39509 | Film No.: 251135216

Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Issuer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)